Menu

Researchers Succeed in Keeping Disembodied Pig Brains Alive

The organs showed neural activity for up to 36 hours, adding fuel to discussions about the ethics of future neuroscientific research.

May 1, 2018
Catherine Offord

FLICKR, NICK SALTMARSHA team of US researchers has kept disembodied pig brains alive in a comatose-like state for up to 36 hours, according to a report published last week (April 25) by MIT Technology Review. First revealed by Yale University neuroscientist Nenad Sestan at a meeting held on March 28 at the National Institutes of Health, the results have increased the urgency of the ethical debate surrounding the future of brain research.

Although other groups have managed to keep disembodied brainstems and hearts of rodents alive, the current project is noteworthy for the scale of the brain being preserved, and its apparent success. The results have yet to be published in a scientific journal.

The researchers achieved the feat by experimenting with more than 100 pig brains obtained from a slaughterhouse, Sestan disclosed at the meeting (via MIT Technology Review). While maintaining circulation to the organs with a setup of pumps and heated-up blood, the team observed normal-like patterns of cell activity, even though the brains were only attached to the setup several hours after the pigs were killed—meaning at least some cell death and damage to the organs would be likely.

“These brains may be damaged, but if the cells are alive, it’s a living organ,” Steve Hyman, director of psychiatric research at the Broad Institute in Cambridge, Massachusetts and one of the scientists briefed on the work, tells MIT Technology Review. “It’s at the extreme of technical know-how, but not that different from preserving a kidney.”

The reaction to the news has been mixed, The Guardian reports. Frances Edwards, a neuroscientist at University College London, notes that the technique could allow researchers to study animals’ neural networks in greater detail and develop better imaging techniques. But it’s unlikely to be replicated in humans, she adds.

“It would be a major, pretty much impossible step even to get this far with a human brain,” she tells The Guardian. “In the pig, you are taking a healthy animal and able to control exactly when and how it dies and immediately take out the brain.” In humans, instead, “by the time the brain is accessible it would be well and truly compromised.”

Nevertheless, several researchers argue that the time to consider the ethical implications of such research being carried out with human tissue is now, while brain preservation techniques, along with the development of brain surrogates such as chimaeras and brain organoids, are under development.

See “Human Brain Organoids Thrive in Mouse Brains

Writing last week (April 25) in Nature, Sestan, along with Hyman, biologist George Church, and 14 others, urged colleagues and the public to address questions such as “Who, if anyone, should ‘own’ ex vivo brain tissue, brain organoids or chimaeras?” and “Do ex vivo human brain models challenge our understanding of life and death?”

Neurobiologist Colin Blakemore of the School of Advance Study at the University of London tells BBC News that he seconds the authors’ message. “It is very, very important that there should be a public discussion about this,” he says, “not least because the researchers who have some investment can tell the public why it would be so important to develop such techniques.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.